Cargo Therapeutics logo

Cargo Therapeutics Share Price (NASDAQ: CRGX)

$4.48

▲

-0.06

(-1.32%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 18 Aug 2025

Check the interactive Cargo Therapeutics Stock chart to analyse performance

Cargo Therapeutics Key Stats

Check Cargo Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.54
Open
$4.5
Market Capitalization
$219.6M
Today's Volume
$10.9M
Revenue TTM
$0.0
EBITDA
$-153.0M
Earnings Per Share (EPS)
$-4.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-65.83%

Analyst Recommendation on Cargo Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cargo Therapeutics(by analysts ranked 0 to 5 stars)

About Cargo Therapeutics

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.
Organization
Cargo Therapeutics
Employees
167
CEO
Mr. Anup Radhakrishnan
Industry
Miscellaneous

Key Management of Cargo Therapeutics

NameTitle
Mr. Anup Radhakrishnan
Interim CEO, CFO, Secretary, COO & Director
Dr. Crystal L. Mackall M.D.
Co-Founder & Scientific Advisory Board Chair
Dr. Robbie Majzner M.D.
Co-Founder & Scientific Advisory Board Member
Ms. Nancy Goodman J.D.
Founder
Dr. Louai Labanieh Ph.D.
Founder
Ms. Halley E. Gilbert Esq., J.D.
Chief Legal Officer
Ms. Kari E. Leetch
Chief People Officer

Important FAQs about investing in CRGX Stock from India :

What is Cargo Therapeutics share price today?

Cargo Therapeutics share price today is $4.48 as on . Cargo Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Cargo Therapeutics share?

Cargo Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cargo Therapeutics stock price today i.e. is trending at $4.48, lower by 82.4% versus the 52 week high.

How to invest in Cargo Therapeutics Stock (CRGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cargo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cargo Therapeutics Shares that will get you 0.3348 shares as per Cargo Therapeutics share price of $4.48 per share as on August 18, 2025 at 12:00 am IST.

What is the minimum amount required to buy Cargo Therapeutics Stock (CRGX) from India?

Indian investors can start investing in Cargo Therapeutics (CRGX) shares with as little as ₹87.6463 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Cargo Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Cargo Therapeutics share’s latest price of $4.48 as on August 18, 2025 at 12:00 am IST, you will get 2.2321 shares of Cargo Therapeutics. Learn more about fractional shares .

What are the returns that Cargo Therapeutics has given to Indian investors in the last 5 years?

Cargo Therapeutics stock has given 0.0% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?